1. General comments 1.1. The paper is most interesting. The cost effectiveness of this alternative fracture pathways is highlighted, and also the use of discrete event simulation as a basis for detailed costing has significant potential 1.2. A number of specific comments are offered below but my main concern is that the role of the simulation should be explained more clearly, emphasising its potential benefits in comparison to other approaches. See 2.3, 2.6, 2.7, 2.8. 1.3. I have clicked on "No" in response to several items on the review checklist. This creates a very negative impression whereas I suspect that my comments can actually be addressed relatively easily.
2. Specific comments 2.1. The word "pragmatic" (line 48, p.3) needs some elaboration. It suggests that there is a reduction in rigour in order to deliver useful results. This may be a most reasonable trade-off but needs some (brief) discussion. 2.2. Perhaps "perversely" (line 23, p.5) should be omitted? 2.3. Although the characteristics of DES are described (lines 6-18, p.7), a fuller explanation of the role of DES is needed: why are costings based on this kind of modelling better than the alternatives (e.g. top-down or simple pathway models of sequences of activities with mean values of resource utilisations). 2.4. The description of the "patient"s journey" could benefit from a little more detail (lines 46-48, p.10). 2.5. The validation of the DES model is discussed (lines 2-3, p.11); a Table 1 p. 7-8: The VFC has 12 patient arrivals per day and the TFC has 18 arrivals per day. Please explain in detail why these values are different. What is happening to the patients that would normally attend the TFC that do not attend the VFC? Do these patients simply not require follow-up, or are they being managed elsewhere? If they are being managed elsewhere, the cost and effect implications of this management should be captured otherwise the model is not comparing "like with like". Are other costs being borne outside the VFC that would traditionally be captured in the TFC? (e.g. dressing changes, cast removal, etc) If so, are these costs captured appropriately in the model? Are any costs applied to those patients that are not referred from ED into the VFC or those that are discharged from the virtual clinic without further follow up? Is this appropriate? What are the implications of this major assumption? What perspective is this analysis taking? Table 1 p. 7-8: Does the VFC pathway never result in the need for xray? Table 1 p. 7-8: VFC decision point: Does the model capture the costs of follow-up for the 40% of patients referred to the consultant clinic, etc? Table 1 p. 7-8: How was the "warm up" period chosen? What is the effect of altering this parameter? Table 1 p. 7-8: How was the "efficiency level" chosen? What is the effect of altering this parameter? How was it determined that 20 runs of the model were appropriate to account for stochastic variation in the results? Did the model include queues? If so, what was the queueing discipline used in these queues (e.g. FIFO)? Was baulking or reneging applied in the model, how was this applied? P9 Line 43: The researchers" state: The institution"s finance department provided the salary mid-point for each staff group. It would appear more appropriate to use mean salary for this calculation rather than median salary. P9 Line 45-46: The researchers" state: Since the same costs were used in each model for comparison purposes, discounting of costs and benefits was not used. This is not appropriate. While the unit costs inputs applied in each analysis may be the same, the total costs accrued in the model over time will be different for each treatment pathway; therefore, discounting should be applied appropriately in the analysis. Does the model capture any capital or consumable costs? As the authors discuss many of the TFC inputs are based on expert opinion as this service was no longer active at the location of interest. However, there is little in the way of sensitivity analyses across plausible ranges in the input parameter values presented in the manuscript. While the research presents uncontrolled data on patient satisfaction and PROM values from patients that have been processed through the VFC pathway there are no data presented that directly compare these results with the TFC pathway. This makes it difficult to ascertain the precise incremental difference in patient outcomes for VFC versus TFC. While the analysis presents the effects of stochastic uncertainty through averaging the results of repeated model runs, the exploration of parameter uncertainty is lacking. The analysis would very much benefit from more detailed sensitivity analyses exploring the effect of altering input parameter values over plausible ranges on the model"s output. This could be explored using univariate, multivariate and perhaps probabilistic sensitivity analyses as appropriate. Summary In the reviewer"s opinion, this work would be better framed as a "cost-comparison" with a discussion of the VFC outcomes rather than a formal "cost-effectiveness" analysis. The manuscript would benefit from more detailed sensitivity analyses exploring the effect of altering input parameter values. The potential cost borne by other sectors/persons for those patients not referred from ED into the VFC or those that are discharged from the virtual clinic without further follow up should be explored in detail. Other issues: Page 4 Row 8-9. The researcher states: Traditional fracture clinics are an example of unnecessary duplication in medicine. Is this the case for all fracture clinics and visits to fracture clinics? Isn"t this perhaps pre-empting the results of this research. Perhaps re-word. Fully describe each acronym at first mention (e.g. PROMS) Please specify the denominator of the resource use time periods (e.g Nurse prep time period of 1.61 minutes per patient? etc) By convention, new results should be presented first in the Results section, not in the Discussion. For instance, sensitivity analysis results are presented in the discussion on p. 15 lines 51-55 as follows: Even if we make the assumption that the TFC patients take 50% less time for both of the consultant consultations and the treatment time the TFC still costs more (£25.31 (95%CI: 24.67, 25.09)) than a VFC. In Figure 2 do all VFC patients receive a "consultant" review or are some assessed solely by a nurse? 
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GENERAL COMMENTS
The paper represents a good example of care service re-design using pathways (i.e. Glasgow Fracture Pathway). Discrete Event Simulation (DES) was used in order to estimate the cost effectiveness of the implemented pathway. The paper is generally easy to read, the model assumptions are clearly outlined, and a few limitations are mentioned as well. Further, the results presented support the conclusions drawn. However, there are some issues to be considered within the final version as mentioned below.
Major Concerns: 1. Introduction:
The introduction needs to be richer by providing much more preliminary information about the topics of pathways and valuebased healthcare in general. This can help the reader to get more understanding about the scope and importance of the study.
Literature Review:
Over the past few years, the modeling and simulation of care pathways has been an active area of research for improving healthcare delivery. Therefore, I believe that the study needs to review the state-of-the-art studies in relation to pathways modeling in a broader sense. Minor Concerns: Please describe in detail the simulation model entities. The timing /events within the simulation model should be clearly illustrated in the conceptual model. Such information can be visually presented on the VFC process map (i.e. Figure 1 ). The acronym (DES) should be used consistently through the paper. Patients directly discharged at ED do not have further follow up but have access to a helpline. Those discharged at the VFC again do not have any follow up but have access to the helpline and can "opt in" if they have specific problems. All information and discussion with patients by the nursing staff is logged and can be accessed by anyone in the orthopaedic department. If they are being managed elsewhere, the cost and effect implications of this management should be captured otherwise the model is not comparing "like with like". There are no additional cost for these patients, apart from the calls to the helpline and these have been included in the model. Are other costs being borne outside the VFC that would traditionally be captured in the TFC? (e.g. dressing changes, cast removal, etc) We have modified the patient pathway figures to make it clearer that some patients do need to be seen f2f after VFC review. We have made the assumption that the costs and timings for the TFC are the same in either pathway. However, in reality the patients seen f2f in the VFC pathway may be more complex and we have stated this a s a limitation of the work. It would be something worth investigating further though. If so, are these costs captured appropriately in the model? Hopefully the answer above address this question.
VERSION 1 -AUTHOR RESPONSE
Are any costs applied to those patients that are not referred from ED into the VFC or those that are discharged from the virtual clinic without further follow up? There are no costs associated with those discharged at ED (Vardy, et. al. 2013) . Those discharged from the VFC do have a cost associated in terms of their access to the telephone helpline. Is this appropriate? What are the implications of this major assumption? This is entirely appropriate and the ED report that it brought significant benefits to their service. This was due to better collaboration and cooperation with orthopaedics, which continues even now. We have referenced the paper written by ED consultants. What perspective is this analysis taking? We have completed a cost comparison and only take account of costs that are significantly different between the two pathways, focusing on staff costs. We apologise for not making the pathways clearer and have rectified this by updating Fig. 1 and Fig.  2 . The VFC pathway does result in some patients being seen f2f and this has been included in the cost comparison. Both models included queues before each of the activities to account for queuing of both virtual and real patients. These were based on FIFO. We did not include reneging or baulking as these are people who want to be seen and are willing to wait until their injury has been assessed. Often TFC"s clinics would overrun their scheduled time, into staff lunchbreaks or another doctor would be called upon to make sure everyone waiting was seen. P9 Line 43: The researchers" state: The institution"s finance department provided the salary mid-point for each staff group. It would appear more appropriate to use mean salary for this calculation rather than median salary. This was an error or our part and the mean salary was used. P9 Line 45-46: The researchers" state: Since the same costs were used in each model for comparison purposes, discounting of costs and benefits was not used. This is not appropriate. While the unit costs inputs applied in each analysis may be the same, the total costs accrued in the model over time will be different for each treatment pathway; therefore, discounting should be applied appropriately in the analysis. Since we have done direct comparisons over the same time period to assess the differences between the two pathways we believe that we do not need to include discounting. We have not found any evidence for long term cost differences therefore discounting is not an issue. Does the model capture any capital or consumable costs? No capital or consumable costs are included.
As the authors discuss many of the TFC inputs are based on expert opinion as this service was no longer active at the location of interest. However, there is little in the way of sensitivity analyses across plausible ranges in the input parameter values presented in the manuscript. Much of these routing values are based on the clinical mix of patients and therefore does not warrant sensitivity analysis. Sensitivity analysis was necessary in terms of the staffing levels. We experimented in conjunction with the experts so that the number of staff required to ensure all patients were seen within the allocated session time was achieve. The values shown in the table represent the necessary staffing required as agreed with the experts. While the research presents uncontrolled data on patient satisfaction and PROM values from patients that have been processed through the VFC pathway there are no data presented that directly compare these results with the TFC pathway. This makes it difficult to ascertain the precise incremental difference in patient outcomes for VFC versus TFC. Your point is entirely valid however they did not routinely collect data on patient satisfaction and PROMS from trauma patients in orthopaedics prior to this work and we agree that this is a limitation.
Based on discussions and interviews with the team at the hospital, TFC"s were extremely busy and staff had to cope with multiple complaints. The redesign was initiated in response to this issue. We have included the issue of PROMS in the study limitations section While the analysis presents the effects of stochastic uncertainty through averaging the results of repeated model runs, the exploration of parameter uncertainty is lacking. The analysis would very much benefit from more detailed sensitivity analyses exploring the effect of altering input parameter values over plausible ranges on the model"s output. This could be explored using univariate, multivariate and perhaps probabilistic sensitivity analyses as appropriate.
We have created some charts (Fig.3 ) that show sensitivity of costs to efficiency and arrival rates.
Summary
In the reviewer"s opinion, this work would be better framed as a "cost-comparison" with a discussion of the VFC outcomes rather than a formal "cost-effectiveness" analysis. We agree with this opinion and have subsequently changed the paper title. The manuscript would benefit from more detailed sensitivity analyses exploring the effect of altering input parameter values. We have done this for efficiency, and arrival rates and charted the effects on costs. The potential cost borne by other sectors/persons for those patients not referred from ED into the VFC or those that are discharged from the virtual clinic without further follow up should be explored in detail.
We have discussed in the paper that there is no cost for those discharged at ED and from the VFC other than access to the telephone helpline and the nurse time which is included in the model.
Other issues:
Page 4 Row 8-9. The researcher states: Traditional fracture clinics are an example of unnecessary duplication in medicine. Is this the case for all fracture clinics and visits to fracture clinics? Isn"t this perhaps pre-empting the results of this research. Perhaps re-word. Of course you are correct that not all fracture clinics see patients unnecessarily. However, what the redesign has accomplished is the development of standard protocols that mean only patients who genuinely need to be seen face to face will have to attend a clinic. Studies have shown that some stable fractures can be managed by self-care and this was implemented as part of the redesign Fully describe each acronym at first mention (e.g. PROMS) done
Please specify the denominator of the resource use time periods (e.g Nurse prep time period of 1.61 minutes per patient? etc) I think there has been some confusion about Table 1 . This has been modified to clearly indicate that we have used a mean and standard deviation. By convention, new results should be presented first in the Results section, not in the Discussion. For instance, sensitivity analysis results are presented in the discussion on p. 15 lines 51-55 as follows: Even if we make the assumption that the TFC patients take 50% less time for both of the consultant consultations and the treatment time the TFC still costs more (£25.31 (95%CI: 24.67, 25.09)) than a VFC. This has been moved as you suggested.
In Figure 2 do all VFC patients receive a "consultant" review or are some assessed solely by a nurse? All VFC patients are reviewed without them being present. They are reviewed by both a consultant and Nurse and take into account all the electronic data about the patient including their ED review about the injury and any imaging. The case hospital have electronic health records and online access to imaging. 2. Since TFC is the traditional approach, there must be costs setting up as well as maintaining VFC compared to TFC. Since this transition is complete (the VFC is in the past) and the costs are therefore not included. The impact on the analysis is similar to ignoring the introduction costs of a new technology which could be significant. Please comment on this.
The introduction of the VFC did not incur any new costs as it was based on reorganisation of existing resources, doing things in a different way. No new equipment was purchased. 3. page 12 -please be more specific about how TFC model was validated by 'individual elements of the model' or 'available data'. So which parts are not validated? Also there is no figure showing TFC pathway in parallel to the one showing VFC to facilitate understanding of the model. In addition, the model generated number of staffs needed to reduce the queue within TFC -might it be possible to validate this using administrative data within the hospital?
We have updated fig 1 and fig 2 to make the understanding of the differences clearer. Historically TFC"s often over ran the session time allocated meaning patients waited past their allocated timeslot. The modelling highlighted this, showing that more than 2 doctors were required if the clinics were not to overrun. Junior doctors are often utilised in this pathway, meaning the patient does not always see a consultant 4. The paper represents a good example of care service re-design using pathways (i.e. Glasgow Fracture Pathway). Discrete Event Simulation (DES) was used in order to estimate the cost effectiveness of the implemented pathway.
The paper is generally easy to read, the model assumptions are clearly outlined, and a few limitations are mentioned as well. Further, the results presented support the conclusions drawn. However, there are some issues to be considered within the final version as mentioned below. Thank you for your comments on the paper.
The introduction needs to be richer by providing much more preliminary information about the topics of pathways and value-based healthcare in general. This can help the reader to get more understanding about the scope and importance of the study. We have included some new references to address this important point. 2. Literature Review:
Over the past few years, the modeling and simulation of care pathways has been an active area of research for improving healthcare delivery. Therefore, I believe that the study needs to review the state-of-the-art studies in relation to pathways modeling in a broader sense. Examples are:
• Zeigler, B.P., 2016. Discrete event system specification framework for self-improving healthcare service systems. IEEE Systems Journal.
• We have included some of these important studies as well as some additional ones, especially in discussion of pathways. We modelled the first step in the patient pathway from ED as a way to compare different pathway costs. Some of these articles detail tracking of individual patients as a means of fee for performance. While we recognise that there are some similarities they do not relate directly to this work. We are taking a simpler approach than Zeigler and refer to this specifically in the text.
Model Validation and Verification:
Please mention with more details the model verification tests that were conducted (e.g. structureverification test, extreme conditions test, and parameter-verification test).
Please evidently demonstrate the similarity between the model output and the real dataset. It is not enough to say that they were similar. Comparative charts should be used to demonstrate the model validity and its closeness to reality. We have attempted to address this comment in the validation section of the paper. 4. Paper organisation: Some sections can be clearer if re-organised or broken into smaller ones. Specifically: -The data collection section may be mentioned before the simulation variables/parameters. -The model verification and validation should have its own section apart from the Results and Discussion sections. We have done as you suggested.
Minor Concerns: Please describe in detail the simulation model entities. The timing /events within the simulation model should be clearly illustrated in the conceptual model. Such information can be visually presented on the VFC process map (i.e. Figure 1 ).
The acronym (DES) should be used consistently through the paper. We have updated both figures and in the validation section we have discussed model entities.
VERSION 2 -REVIEW
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GENERAL COMMENTS
What perspective is the analysis taking? To clarify, my query here was intended to clarify the general perspective of the analysis i.e. from which "entities" perspective are you capturing costs? For example, are you taking a hospital perspective, health care perspective, government perspective, societal perspective -or some other perspective? If the perspective is some hybrid of these please just describe it as accurately as possible. This will aid the reader in quickly determining which costs you have incorporated in your model and which you have not.
Discounting:
The authors have reiterated that they have conducted direct comparisons over the same time period to assess the differences between the two pathways we believe that we do not need to include discounting. This argument does not really support the exclusion of discounting. However, it appears that the model was only run for a period of one year. If this is the case, then discounting is not required and this rationale should be used in the manuscript.
Capital or consumable costs: Please note within the manuscript that the model does not capture these costs.
Any additional costs post discharge from ED:
The authors have gone someway to answering this query -however -I am still unclear what data were collected on patients in the VFC pathway post-discharge from ED. I"m attempting to ascertain if some of these patients" costs have shifted outside of the hospital system and are being borne elsewhere. The reference cited by the researchers (Vardy et al., 2013) states that they prospectively collected administrative data from the electronic patient record system. Do these data capture the use of community services, outpatient services or patient out of pockets which may have been incurred in these patients? These may well have been beyond the scope of your research which is understandable. If so, can you please state that these costs are not included in your analysis. Table 3 rows 22-34: Presumably these are these total annual costs? For clarity please add annual to this description of costs.
Minor issues
Typographical errors p. 9, row 13-15 "routinings" "likley"
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